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Several alphaviruses, including the Sindbis-group viruses, Ross River virus, O’nyong-nyong virus, and
Chikungunya virus, are associated with outbreaks of acute and persistent arthralgia and arthritis in humans.
Mechanisms underlying alphavirus-induced arthralgia and arthritis are not clearly understood, though direct
viral replication within or around the affected joints is thought to contribute to disease. S.A.AR86 is a
Sindbis-group alphavirus closely related to the arthralgia-associated Ockelbo and GirdwoodS.A viruses.
Following inoculation with S.A.AR86 derived from a molecular clone, infectious virus was isolated from bone
and joint tissue 1 to 6 days postinfection. Studies using either in situ hybridization or S.A.AR86-derived double
promoter viruses and replicons expressing green fluorescent protein localized sites of viral replication to the
periosteum, tendons, and endosteum within the epiphyses of the long bones adjacent to articular joints. These
results demonstrate that alphaviruses associated with arthralgia in humans replicate within bone-associated
connective tissue adjacent to articular joints in an adult mouse model.
Several Old World alphaviruses, including the Sindbis-group
viruses, Ross River virus, O’nyong-nyong virus, and Chikungu-
nya virus, are associated with outbreaks of acute and persistent
arthritis and arthralgia in humans (reviewed in reference 10).
Chikungunya and O’nyong-nyong viruses have caused massive
epidemics of acute, debilitating arthralgia in Africa and Asia
(reviewed in reference 10). Ross River virus, the etiologic
agent of epidemic polyarthritis, is endemic to Australia (2, 10,
28), and it caused a major epidemic that swept the South
Pacific islands in 1979, affecting 50,000 people on the island of
Fiji (1). Sindbis-group alphaviruses, including Ockelbo virus,
Karelian fever virus, and GirdwoodS.A. virus, are associated
with acute and persistent arthralgia in northern Europe and
South Africa (14, 26, 29). Ockelbo disease, one of the best
characterized of the Sindbis-group alphavirus arthralgias, is
often incapacitating (10, 29), and one study found that symp-
toms lasted for months to years in 31% of patients [(B. Niklas-
son and Å. Espmark, Letter, Lancet i:1039–1040, 1986). Symp-
toms include arthralgia in one or more joints, including large
joints such as the knee, hip, and elbow (reviewed in references
10 and 29). Pain within or around tendons is also a common
trait of Sindbis-group virus infections (reviewed in reference
10). Rubella virus, another member of the family Togaviridae
that is distantly related to the alphaviruses, is also associated
with acute and persistent arthritis in humans (reviewed in
reference 33).
Mechanisms underlying togavirus-induced arthralgia and ar-
thritis are not clearly understood, though direct viral replica-
tion within or around the affected joints may contribute to
disease (reviewed in reference 29). Ross River virus antigen
has been detected in cell aspirates from the joints of acutely
infected individuals (6). Furthermore, patients suffering from
persistent arthralgia following Ockelbo virus infection often
have high levels of Ockelbo virus-specific immunoglobulin M,
which suggests that the virus may persistently infect these in-
dividuals (19).
Understanding of the mechanisms leading to alphavirus-
mediated arthritis and arthralgia in humans has been ham-
pered by the lack of a small-animal model. Sindbis-group al-
phaviruses, Semliki Forest virus, and Ross River virus replicate
in bone-associated connective tissue in neonatal mice, but skin
and muscle are also major sites of viral replication (13, 17, 18,
30). Furthermore, infection of neonatal animals with these
viruses results in rapidly fatal disease (13, 17, 18, 30). This
generalized pattern of replication and lethal outcome in neo-
natal mice has limited the usefulness of mice as a model of
bone and/or joint replication by arthralgia-associated alpha-
viruses. Since most Sindbis-group viruses do not cause lethal
disease in adult mice following peripheral inoculation, ex-
periments were performed to evaluate whether bone and/or
joint tissue was a target of Sindbis-group virus infection in
adult mice. These experiments were facilitated by the use of
S.A.AR86, a Sindbis-group virus isolated in South Africa (32).
Sequence comparisons demonstrate that S.A.AR86 is most
closely related to GirdwoodS.A. virus, which was isolated from
a South African patient suffering from arthralgia (14, 20, 25),
and Ockelbo virus, the etiologic agent of Ockelbo disease (24,
26). Full-length infectious cDNA clones of S.A.AR86 are also
available (25). This permits maintenance of the viral genome
without the introduction of attenuating mutations from re-
peated passage in cell culture (12), as well as the construction
of S.A.AR86-based expression vectors.
Six-week-old female CD-1 mice (Charles River Breeding
Laboratories, Raleigh, N.C.) were infected intravenously (i.v.)
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with 103 PFU of virus derived from the wild-type S.A.AR86
molecular clone ps55 (25). Three days postinfection mice were
sacrificed and serum was harvested, while the quadriceps mus-
cles and the femurs (including the knee and hip joints) were
removed and placed in phosphate-buffered saline (PBS) sup-
plemented with 1% donor calf serum (Gibco BRL, Grand
Island, N.Y.). Muscle tissue was frozen and thawed before
homogenization using a mortar and pestle (Kontes Glass Com-
pany, Vineland, N.J.), while calcified tissue was crushed using
sterile pliers before freeze-thaw. The tissue homogenate was
then clarified by centrifugation and assayed for infectious virus
by plaque assay on BHK-21 cells (ATCC CRL 8544) as previ-
ously described (23). Virus was consistently isolated from the
femurs of infected animals (Fig. 1A). Infectious virus could be
isolated from bone and/or joint tissue as early as 24 h and up
to 6 days postinoculation (data not shown). Infectious virus
was also detectable in femurs with similar kinetics following
intraperitoneal and subcutaneous inoculation (data not shown).
The possibility that the virus detected within the bone and/or
joint tissue was actually due to contamination from serum or
surrounding muscle was addressed by measuring virus levels in
these tissues. Serum viremia peaked by 24 to 48 h after i.v.
S.A.AR86 infection (data not shown) and fell below the limit
of detection by 72 h postinoculation (Fig. 1A). Furthermore,
comparison of viral titers from perfused and nonperfused an-
imals found no difference in virus levels within the femur on
day 3 postinfection (data not shown). Since muscle is a site of
Sindbis-group virus replication in suckling mice (13, 30), the
level of viral replication within the quadriceps was measured.
Unlike with neonatal mice, infectious virus was not consistently
isolated from adult mouse muscle tissue (Fig. 1A). This sug-
gests that the infectious virus isolated from the femur was due
to direct viral replication within bone and/or joint tissue rather
than contamination by virally infected muscle tissue.
Additional experiments were performed to determine whether
bone marrow or calcified and fibroblast connective tissue was
the site of virus replication within the hind limb. Adult female
CD-1 mice were infected i.v. with 103 PFU of virus derived
from the S.A.AR86 molecular clone ps51, which differs from
the wild-type ps55 clone by a single coding change (nsP1 Thr
538 to Ile). Three days postinfection the femurs, including the
hip and knee joints, were removed and the bone marrow was
aspirated and titrated for infectious virus by plaque assay. The
remaining tissue, including the diaphysis (barrel) of the femur
and the knee and hip joints, was also titrated. Viral titers were
at or below the limit of detection in bone marrow aspirates,
while the bone and joint tissues had significant levels of virus
(Fig. 1B). Comparable results were obtained following infec-
tion with virus derived from clone ps55, and no difference in
replication within the femur was observed between these two
viruses (data not shown). These results suggest that cells tightly
associated with calcified or fibroblast connective tissue were
the main targets of virus replication.
Sequence and serologic comparisons have grouped S.A.AR86
with GirdwoodS.A. virus and Ockelbo virus, both of which are
associated with arthralgia in humans (14, 20, 24, 25, 26). Other
Sindbis-group alphaviruses, such as the viruses derived from
the AR339 isolate, which are not associated with human dis-
ease, are more distantly related (reviewed in reference 10).
Therefore, experiments were performed to evaluate whether
replication within bone and joint tissues was specific for the
S.A.AR86/GirdwoodS.A./Ockelbo virus subgroup or whether
it was a general characteristic of Sindbis-group alphaviruses.
Six-week-old female CD-1 mice were infected i.v. with 103
PFU of the virus derived from clone ps55 or the cloned
AR339-like Sindbis-group viruses TR339 (12, 16) and TRSB
(16). Three days postinfection hind limbs were removed and
femurs, including the knee and hip joints, were evaluated for
the presence of infectious virus by plaque assay. s55, TR339,
and TRSB replicated to similar levels within bone and joint
tissues (Fig. 1C), suggesting that replication within bone and
FIG. 1. S.A.AR86, as well as other Sindbis-group alphaviruses, replicates in
bone- and joint-associated tissues. (A) Six-week-old female CD-1 mice were
infected with 103 PFU of s55 i.v. Three days postinfection mice were sacrificed,
exsanguinated, and perfused with PBS, and their femurs and quadriceps muscles
were removed by dissection and titrated for infectious virus on BHK-21 cells.
Data are shown as log PFU per gram of tissue for femur and muscle and as PFU
per milliliter for serum. Each bar represents a single animal. The arrow indicates
the limit of detection, and asterisks denote samples below the limit of detection.
Data shown are from one of four experiments. (B) Six-week-old female CD-1
mice were infected i.v. with 103 PFU of s51 and sacrificed 3 days postinfection,
and right femurs were removed for virus titration. Bone marrow was aspirated
from the diaphyses of the femurs using 0.4 ml of PBS–1% donor calf serum per
femur. Aspirates were freeze-thawed and titrated for infectious virus by plaque
assay. Following marrow aspiration, the remaining femoral tissue was processed
as for panel A and titrated for infectious virus by plaque assay. Titer is shown as
total PFU per marrow aspirate (Asp) or femur (without aspirated marrow), with
each bar representing a single animal. The arrow indicates the limit of detection,
and asterisks denote samples with titers below the limit of detection. Shown is
one of three comparable experiments. (C) Six-week-old female CD-1 mice were
infected i.v. with 103 PFU of the virus s55, TR339, or TRSB. Three days postin-
fection mice were sacrificed and both femurs were removed for virus titration.
Femurs were processed and titrated for infectious virus as for panel A. Each bar
represents results from a single animal. The arrow indicates the limit of detec-
tion. N/D, not done. Shown is one of two comparable experiments.
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joint tissues is a general characteristic of Sindbis-group alpha-
viruses rather than a specific attribute of S.A.AR86.
Crude fractionation studies demonstrated that the majority
of infectious S.A.AR86 was within calcified or fibroblast con-
nective tissue of the femur or joints, while little virus was in the
bone marrow aspirates (Fig. 1B). In order to confirm that bone
and/or joint tissue was a target of S.A.AR86 infection and to
identify the specific sites of replication within these tissues,
in situ hybridization using 35S-labeled riboprobes specific for
S.A.AR86 was performed. Mice were infected i.v. with either
103 or 2.5 3 105 PFU of s51, the virus derived from clone ps51,
or mock infected with diluent alone and sacrificed at 24 or 48 h
postinfection. At the time of sacrifice, mice were perfused with
4% paraformaldehyde in PBS (pH 7.4) prior to decalcification
and in situ hybridization. Paraffin-embedded limb sections
were probed using either a riboprobe complementary for
S.A.AR86 nucleotides 7371 to 7816 or a control riboprobe
specific for the influenza virus strain PR/8 hemagglutinin (HA)
as described previously (9). S.A.AR86-specific in situ signal
was observed in the periosteum and tendons of the long bones
adjacent to the joints in mice infected with either dose of virus.
Consistent with virus titration results (Fig. 1A), S.A.AR86-
specific in situ signal was rarely found in muscle tissue. Repli-
cation was also restricted to the epiphyses (ends) of the long
bones adjacent to the joints, while in situ signal was not ob-
served in the diaphyses of the long bones. Specific signal was
not observed in periosteum or tendons from mock-infected
mice probed with the S.A.AR86-specific riboprobe or in tissues
from infected mice probed with the influenza virus HA-specific
riboprobe (Fig. 2 and data not shown). Similar results were
obtained for in situ hybridization of limb sections from mice
infected with s51 by the intracranial route (data not shown).
Although in situ signal was not observed within the synovial
membrane, signal was observed in periosteum and tendons
immediately adjacent to the synovial cavity (Fig. 2D). In addi-
tion to the periosteum and tendons, in situ signal was ob-
served in the endosteum within the epiphyses of the long
bones (data not shown). However, since this signal involved
single infected cells, and since the smaller spaces within the
marrow cavities might lead to nonspecific probe binding, we
FIG. 2. S.A.AR86 replication within the bone-associated connective tissue of the epiphyses (ends) of the long bones. Four- to six-week-old female CD-1 mice were
infected i.v. with 103 or 2.5 3 105 PFU of s51 or mock infected. Mice were sacrificed at 24 or 48 h postinfection. Following decalcification, 5-mm-thick paraffin-embedded
limb sections were probed with 35S-labeled riboprobes specific for S.A.AR86 or influenza virus strain PR/8 HA. (A) S.A.AR86-specific in situ signal in periosteum of
the tibia 24 h after infection with 2.5 3 105 PFU of s51 i.v. M, muscle; B, bone. (B) Adjacent section probed with influenza virus-specific riboprobe. (C) Adjacent section,
hematoxylin and eosin staining. (D) S.A.AR86-specific in situ signal in the tendon and periosteum of the tibia proximal to the knee joint 24 h after infection with 2.5 3
105 PFU of s51 i.v. T, tendon; B, bone. (E) Adjacent section probed with influenza virus-specific riboprobe. (F) Adjacent section, hematoxylin and eosin staining. Bar 5
100 mm in each panel.
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were interested in confirming that the endosteum was truly a
site of viral replicon.
To confirm the in situ hybridization results, mice were in-
fected with S.A.AR86-based vectors driving expression of
green fluorescent protein (GFP). GFP expression provides a
sensitive method of detecting infected cells both in vivo and in
vitro (31). GFP is extremely stable, tolerates the decalcification
conditions used in making sections from bone and joint tissues
(K. Bernard and R. E. Johnston, unpublished data), and pro-
vides a sensitive method for detecting virally infected cells in
calcified tissues.
The first type of viral vector used was an S.A.AR86-based
double promoter vector, which was constructed by placing
a second S.A.AR86 subgenomic promoter immediately up-
stream of the s55 39 untranslated region, as described pre-
viously for other alphaviruses (reviewed in reference 7). This
virus, s55-gfp(F), expressed the mut2 GFP gene (kindly pro-
vided by Stanley Falkow, Stanford University). The original
GFP gene was subsequently replaced with the enhanced GFP
(Clontech, Palo Alto, Calif.) to create the clone ps55-gfp. This
double promoter virus was placed on the s51 background to
create the clone ps51-gfp. Clone ps51-gfp has a single coding
change (nsP1 Thr 538 to Ile), which resulted in a 5- to 10-fold
increase in GFP expression in BHK-21 cells compared to virus
derived from clone ps55-gfp (M. T. Heise, D. A. Simpson, and
R. E. Johnston, unpublished data). GFP expression by the
viruses was stable in vivo, since 100% of plaques isolated from
bone and joint tissues at 3 days postinfection were GFP posi-
tive (data not shown).
Adult CD-1 mice were infected i.v. with 103 PFU or 1 3 106
to 3 3 106 PFU of GFP-expressing double promoter virus. The
103 dose was chosen for direct comparison to studies with s55
or s51 infection (Fig. 1). However, the double promoter viruses
were attenuated for replication in vivo compared to s55 and
s51. Following infection with 103 PFU of s51-gfp or s51, the
double promoter virus produced titers within the femur and
knee joints that were 10-fold lower than those for s51 at 24 h
postinfection. When the dose of s51-gfp was increased to 106
PFU, viral titers within the femur were equal to or higher than
those observed following infection with 103 PFU of s51 (data
not shown). Therefore, additional experiments were per-
formed in which 4-week-old female CD-1 mice were infected
with 1 3 106 to 3 3 106 PFU of s51-gfp i.v. Since s55 and s51
replicate equally well in bone and joint tissues (Fig. 1), most in
vivo experiments were performed using s51-gfp due to its
higher level of GFP expression. However, initial studies using
the 103 dose were performed with the clone ps55-gfp(F). Mice
were sacrificed at 12 to 14 h or 3 days postinfection, exsangui-
nated, and perfused with 4% paraformaldehyde in PBS (pH
7.3), and hind limbs were decalcified. Frozen sections were
then prepared from the decalcified hind limbs. GFP-positive
cells were observed within hind-limb sections from animals
that received either low doses of s55-gfp(F) or high doses of
s51-gfp, but not in mock-infected animals. GFP-positive cells
localized to the same areas with either dose of virus, though
more GFP-positive cells were observed with the high dose.
Consistent with the in situ hybridization studies, GFP-positive
cells localized to bone-associated connective tissue follow-
ing infection with either low (Fig. 3A and B) or high (Fig. 3C
and D) doses of double promoter virus. Furthermore, the
GFP-positive cells localized to both the endosteum and peri-
osteum of the epiphyses of the long bones adjacent to the
joints. The periosteum was a major site of infection, with clus-
ters of GFP-positive cells readily observable adjacent to bone
(Fig. 3C).
In addition to double promoter viruses, S.A.AR86-based
replicons expressing GFP were used to identify sites of
S.A.AR86 infection within bone and/or joint tissue. Alphavi-
rus-derived replicon RNA is packaged with the viral structural
proteins provided in trans by helper RNAs. This results in the
production of replicon particles that exhibit the same coat
proteins as the parental virus, but they are able to undergo only
a single round of replication (reviewed in reference 7). There-
fore, GFP expression by the replicon can be used to identify
the initial cellular targets of viral replication within a given
tissue. An S.A.AR86-based replicon containing the s51 non-
structural genes and driving expression of GFP in place of the
viral structural genes was constructed and designated REP91-
gfp. A glycoprotein helper plasmid was engineered to produce
a helper RNA containing the S.A.AR86 26S subgenomic pro-
moter driving expression of a fusion protein consisting of the
first 74 amino acids of capsid, a 2-amino-acid linker, 17 amino
acids of the foot-and-mouth-disease virus 2A protease (15),
and the viral glycoproteins. The capsid RNA sequence permits
efficient translation of the fusion protein (8), while the foot-
and-mouth-disease virus 2A protease cleaves itself and the
capsid fragment from the E3 glycoprotein to allow glyco-
protein maturation, as shown previously with Semliki Forest
virus-derived replicons (27). The capsid helper was similar
to those described for other alphavirus replicon-packaging
systems (reviewed in reference 7). In vitro-transcribed RNA
from pREP91-gfp, the capsid helper pCAP86, and the glyco-
protein helper pHelp102 was prepared using mMessage mMa-
chine SP6 in vitro transcription kits (Ambion, Austin, Tex.)
and introduced into BHK-21 cells by electroporation (22).
Before the replicon stocks were used in vivo, they were eval-
uated by serial passage of 10 to 20% of the replicon stock on
BHK-21 cells that were examined for cytopathic effect from
propagation-competent recombinant virus. If free of cyto-
pathic effect after two passages, replicon particle stocks were
considered to be usable for experimental purposes.
Mice were infected i.v. with 1 3 106 to 2 3 106 infectious
units of REP91-gfp. Since REP91-gfp is able to undergo only
a single round of replication, high doses of replicon parti-
cles were required for delivery to bone and/or joint tissue.
Mice were sacrificed 12 to 14 h postinfection and frozen sec-
tions were prepared as they were after infection with the dou-
ble promoter viruses. Results with replicons were identical to
those seen with the double promoter viruses s55-gfp(F), s55-
gfp, and s51-gfp. REP91-gfp-infected cells were localized to
the endosteum and periosteum near the ends of the femur and
tibia (Fig. 3E and F). Seventy-eight sagittal sections from the
fore and hind limbs of replicon-infected mice were screened
for GFP-positive cells. These sections included representative
areas of the diaphyses, epiphyses, joints, and surrounding mus-
cle tissue. This screen identified 55 cells that were GFP-posi-
tive, 46 of which were located in the epiphyses of the long
bones. Of these 46 GFP-positive cells, 13 were found in the
endosteum and 33 were found in the periosteum. Of the GFP-
positive cells not clearly located in the epiphyses, all nine were
located in the periosteum or endosteum. Two GFP-positive
cells were located in the periosteum of the diaphysis, and it was
unclear whether the other seven cells were located in the
diaphyses or the epiphyses. No GFP-positive cells were found
in muscle tissue, synovial membrane, or bone marrow not in-
timately associated with calcified tissue. These results, in com-
bination with the in situ hybridization results from Fig. 2,
clearly demonstrate that in an adult mouse model, an alpha-
virus associated with arthralgia in humans exhibits tropism for
bone-associated connective tissue and that the predominant
site of replication is the epiphyses adjacent to the joints.
Mechanisms which lead to joint pain during togavirus infec-
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tion of humans have not been clearly defined. Suggested me-
diators include direct viral replication causing cell death or
damage within the tissue (10), the immune response against
the virus within the joint tissue causing damage to the joint
(10), or immune complex deposition within the joint leading to
inflammation (11). Damage by inflammatory cells elicited by
the virus may occur; however, Sindbis-group alphavirus infec-
tion in humans is associated with a noninflammatory arthralgia
rather than with arthritis (29). Studies with rubella virus- and
Ross River virus-infected patients saw no correlation between
serum immune complexes and/or complement component lev-
els and disease (4, 5). Furthermore, viral antigen has been
isolated from the joint tissue of patients suffering from rubella
virus- and Ross River virus-mediated arthralgia (4, 6, 21).
FIG. 3. S.A.AR86-based double promoter viruses and replicons infect cells within the endosteum and periosteum. Four-week-old female CD-1 mice were infected
i.v. with 103 PFU of the double promoter virus s55-gfp(F) (A and B), 1.5 3 106 PFU of the double promoter virus s51-gfp (C and D), or 2 3 106 infectious units of
the replicon REP91-gfp (E and F). Mock-infected mice received PBS diluent alone. Mice infected with the 103 dose of s55-gfp(F) were sacrificed 3 days postinfection,
while mice receiving high doses of s51-gfp or replicon were sacrificed at 12 to 14 h postinfection. Following sacrifice, mice were perfused with 4% paraformaldehyde,
and hind limbs were decalcified before preparation of frozen sections. GFP-positive cells were visualized by fluorescent microscopy. (A and B) GFP positive cells within
the endosteum of an s55-gfp(F)-infected mouse. Magnification, 3600; triple-pass fluorescein isothiocyanate (FITC)-Texas red filter. (C) GFP-positive cells within the
periosteum of a mouse infected with 1.5 3 106 PFU of s51-gfp. Red staining indicates the presence of type I collagen in calcified tissue, which was identified using
anti-mouse type I collagen (Rockland). Magnification, 3400; triple-pass FITC-Texas red filter. (D) GFP-positive cell adjacent to calcified tissue in an s51-gfp-infected
mouse. Magnification, 3400; FITC filter. (E) GFP-positive cell within the endosteum of a REP91-gfp-infected mouse. Magnification, 3400; triple-pass FITC-Texas red
filter. (F) GFP-positive cells within the periosteum of a REP91-gfp-infected mouse. Magnification, 3400; triple-pass FITC-Texas red filter. Abbreviations: B, bone; M,
muscle; P, periosteum; mc, marrow cavity.
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Therefore, the finding that S.A.AR86 targets tissues that sur-
round the joint is consistent with the idea that arthralgia-
associated alphaviruses replicate within or around joint tissue.
We did not observe inflammation in the S.A.AR86-infected
endosteum or periosteum. However, long-term evaluation of
the effects of S.A.AR86 infection on bone-associated connec-
tive tissue will be required to fully evaluate this issue.
Several important questions remain to be addressed with
regard to S.A.AR86 pathogenesis within the infected bone-
associated connective tissues. These include the following.
(i) What determines S.A.AR86 tropism for bone-associat-
ed connective tissues? (ii) Since osteoblasts and osteoclasts
are the major cell types in the endosteum and periosteum
(3), which cell type or types does the virus infect within these
tissues? (iii) What effect does viral infection have on cellular
function within the infected periosteum, endosteum, or ten-
don? (iv) How long does the virus persist within the infected
tissue? The ability to use a molecularly cloned virus and virus-
based expression systems in a small-animal model should pro-
vide valuable insight into these aspects of togavirus pathogen-
esis.
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